A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes Mellitus

Clinical trial NCT02239354 · TERMINATED

Trial details

NCT number: NCT02239354
Sponsor: ViaCyte
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2014-09-01
Primary completion: 2017-12-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.